-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Immunotherapy can activate the systemic anti-tumor immune effect, inhibit tumor growth, metastasis and recurrence, and has shown great potential in clinical tumor treatment
Iron death is a new type of cell death caused by iron-dependent lipid peroxidation discovered in recent years
Based on the above research background, the Haijun Yu team of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences proposed a strategy to use the acid-sensitive drug delivery system to synergistically induce tumor cell iron death and immunogenic death, thereby improving the anti-tumor immune response
Research data shows that the nanoparticles encapsulating RSL-3 can be selectively enriched in tumor tissues through the EPR effect, and the application of external light can induce the immunogenic death of tumor cells, initiate anti-tumor immune responses, and induce the secretion of cytotoxic T lymphocytes.
Related research results were published in Advanced Materials on June 25, 2021.
Full text link: https://onlinelibrary.
Figure 1.
(Contributor: Yu Haijun Research Group; Contributor: Li Tianliang)